These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11212710)

  • 1. [Diseases associated with C1q abnormalities].
    Ohno T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):253-6. PubMed ID: 11212710
    [No Abstract]   [Full Text] [Related]  

  • 2. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against C1q in systemic lupus erythematosus.
    Siegert CE; Breedveld FC; Daha MR
    Behring Inst Mitt; 1993 Dec; (93):279-86. PubMed ID: 8172577
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance.
    Roumenina LT; Sène D; Radanova M; Blouin J; Halbwachs-Mecarelli L; Dragon-Durey MA; Fridman WH; Fremeaux-Bacchi V
    J Immunol; 2011 Oct; 187(8):4369-73. PubMed ID: 21930969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complement deficiency, immunocomplexes and lupus erythematosus].
    Vivanco Martínez F
    Rev Clin Esp; 1987 Mar; 180(5):264-8. PubMed ID: 3602524
    [No Abstract]   [Full Text] [Related]  

  • 9. [C1q-bound immune complex].
    Yoshida H
    Nihon Rinsho; 1999 Nov; 57 Suppl():90-2. PubMed ID: 10635783
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement. Second of two parts.
    Walport MJ
    N Engl J Med; 2001 Apr; 344(15):1140-4. PubMed ID: 11297706
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic and prognostic significance of indicators of humoral and cellular immunity in patients with lupus erythematosus].
    Konstantinova NA; Koval'chuk LV; Cheredeev AN; Mattess Kh; Trofimova LIa
    Sov Med; 1983; (5):30-4. PubMed ID: 6612458
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.
    Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A
    Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement deficiencies in humans and animals: links to autoimmunity.
    Lewis MJ; Botto M
    Autoimmunity; 2006 Aug; 39(5):367-78. PubMed ID: 16923536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus.
    Finke D; Randers K; Hoerster R; Hennig H; Zawatzky R; Marion T; Brockmann C; Klempt-Giessing K; Jacobsen K; Kirchner H; Goerg S
    Eur J Immunol; 2007 Jun; 37(6):1702-9. PubMed ID: 17506029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating immune complexes in systemic lupus erythematosus].
    Font J; Cardellach F; Mirapeix E; Martorell J; Ingelmo M
    Med Clin (Barc); 1982 Dec 1-31; 79(10):478. PubMed ID: 7154732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.